SC
Snehaben Chintankumar Patel
About Snehaben Chintankumar Patel
Data last updated:
Snehaben Chintankumar Patel is a Director at Small I Pharmaceutical Private Limited (since 2024) and Designated Partner at Vineeion Global Llp (since 2019). The companies operate in Business Services. The largest current company by reported revenue is Small I Pharmaceutical Private Limited at ₹1.2 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Small I Pharmaceutical Private Limited U46497GJ2024PTC155089 | Director | 10 Sep 2024 | 2024 | ₹1.2 Lakh (FY 2025) | Active |
 Vineeion Global Llp AAO-7566 | Designated Partner | 03 Apr 2019 | 2019 | Active |
Board colleagues of Snehaben Chintankumar Patel
| Name | DIN | Company | Designation |
|---|---|---|---|
| Chintan Narsinhbhai Patel | 10774296 | Small I Pharmaceutical Private Limited | Managing Director |
| Raksha Jaydipkumar Patel | 08410934 | Vineeion Global Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Snehaben Chintankumar Patel
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Snehaben Chintankumar Patel
Snehaben Chintankumar Patel currently holds 2 directorships: Small I Pharmaceutical Private Limited (Director, since 10 Sep 2024, revenue ₹1.2 Lakh (FY 2025)); Vineeion Global Llp (Designated Partner, since 03 Apr 2019).
Snehaben Chintankumar Patel was first appointed on 03 Apr 2019 as Designated Partner at Vineeion Global Llp. The most recent appointment on record is 10 Sep 2024 at Small I Pharmaceutical Private Limited.
The current boards of Snehaben Chintankumar Patel's companies include Chintan Narsinhbhai Patel (Small I Pharmaceutical Private Limited), Raksha Jaydipkumar Patel (Vineeion Global Llp).